Helius Medical Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US42328V8019
USD
2.16
0.1 (4.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
NeuroMetrix, Inc.
Sharps Technology, Inc.
Ekso Bionics Holdings, Inc.
Vivos Therapeutics, Inc.
Helius Medical Technologies, Inc.
Seastar Medical Holding Corp.
Creative Medical Technology Holdings, Inc.
ENDRA Life Sciences, Inc.
Aethlon Medical, Inc.
BioRestorative Therapies, Inc.
Navidea Biopharmaceuticals, Inc.

Why is Helius Medical Technologies, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Helius Medical Technologies, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Helius Medical Technologies, Inc.
-99.27%
0.01
4953.70%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.71%
EBIT Growth (5y)
1.57%
EBIT to Interest (avg)
-16.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.21
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.13%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.59
EV to EBIT
2.19
EV to EBITDA
2.19
EV to Capital Employed
0.12
EV to Sales
-33.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.55%
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
NET SALES(HY)

At USD 0.74 MM has Grown at 217.6%

ROCE(HY)

Highest at 0%

RAW MATERIAL COST(Y)

Fallen by -129.93% (YoY

CASH AND EQV(HY)

Highest at USD 130.13 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 3.59 times

EPS(Q)

Highest at USD -32.89

-31What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -12.72 MM

DEBT-EQUITY RATIO (HY)

Highest at 81.4 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.52 times

INTEREST(Q)

Highest at USD 194.74 MM

OPERATING PROFIT(Q)

Lowest at USD -4.91 MM

PRE-TAX PROFIT(Q)

Lowest at USD -199.81 MM

NET PROFIT(Q)

Lowest at USD -199.81 MM

Here's what is working for Helius Medical Technologies, Inc.

Net Sales
At USD 0.74 MM has Grown at 217.6%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

EPS
Highest at USD -32.89
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 130.13 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 3.59 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -129.93% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Helius Medical Technologies, Inc.

Pre-Tax Profit
At USD -199.81 MM has Fallen at -5,079.06%
over average net sales of the previous four periods of USD -3.86 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -199.81 MM has Fallen at -5,079.06%
over average net sales of the previous four periods of USD -3.86 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -12.72 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest
At USD 194.74 MM has Grown at 30,910.19%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at 81.4 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 0.52 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest
Highest at USD 194.74 MM
in the last five periods and Increased by 30,910.19% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit
Lowest at USD -4.91 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -199.81 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -199.81 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)